519 related articles for article (PubMed ID: 32973686)
1. Guizhi Fuling Wan, Chinese Herbal Medicine, Ameliorates Insulin Sensitivity in PCOS Model Rats With Insulin Resistance via Remodeling Intestinal Homeostasis.
Zhu Y; Li Y; Liu M; Hu X; Zhu H
Front Endocrinol (Lausanne); 2020; 11():575. PubMed ID: 32973686
[TBL] [Abstract][Full Text] [Related]
2. Guizhi Fuling Wan reduces autophagy of granulosa cell in rats with polycystic ovary syndrome via restoring the PI3K/AKT/mTOR signaling pathway.
Liu M; Zhu H; Zhu Y; Hu X
J Ethnopharmacol; 2021 Apr; 270():113821. PubMed ID: 33460753
[TBL] [Abstract][Full Text] [Related]
3. Liuwei Dihuang Pills alleviate the polycystic ovary syndrome with improved insulin sensitivity through PI3K/Akt signaling pathway.
Qiu Z; Dong J; Xue C; Li X; Liu K; Liu B; Cheng J; Huang F
J Ethnopharmacol; 2020 Mar; 250():111965. PubMed ID: 31185267
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of different forms of Guizhi Fuling Wan on reproduction and metabolism in women with polycystic ovary syndrome: A protocol for a meta-analysis of randomized controlled trials.
Liu M; Zhu H; Hu X; Zhu Y; Chen H
Medicine (Baltimore); 2020 Oct; 99(44):e22954. PubMed ID: 33126363
[TBL] [Abstract][Full Text] [Related]
5. The ameliorating effects of Guizhi Fuling Wan combined with rosiglitazone in a rat ovarian model of polycystic ovary syndrome by the PI3K/AKT/NF-κB and Nrf2/HO-1 pathways.
Ye Y; Zhou W; Ren Y; Lu J; Chen A; Jin R; Xuan F
Gynecol Endocrinol; 2023 Dec; 39(1):2254848. PubMed ID: 37706434
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the therapeutic potential of moxibustion on polycystic ovary syndrome: a rat model study on gut microbiota and metabolite interaction.
Lin Y; Zeng H; Lin J; Peng Y; Que X; Wang L; Chen L; Bai N
Front Cell Infect Microbiol; 2024; 14():1328741. PubMed ID: 38665877
[TBL] [Abstract][Full Text] [Related]
7. Qi Gong Wan ameliorates adipocyte hypertrophy and inflammation in adipose tissue in a PCOS mouse model through the Nrf2/HO-1/Cyp1b1 pathway: Integrating network pharmacology and experimental validation in vivo.
Zheng R; Shen H; Li J; Zhao J; Lu L; Hu M; Lin Z; Ma H; Tan H; Hu M; Li J
J Ethnopharmacol; 2023 Jan; 301():115824. PubMed ID: 36273747
[TBL] [Abstract][Full Text] [Related]
8. Exploring the efficacy and mechanism of Bailing capsule to improve polycystic ovary syndrome in mice based on intestinal-derived LPS-TLR4 pathway.
Guan HR; Li B; Zhang ZH; Wu HS; Wang N; Chen XF; Zhou CL; Bian XR; Li L; Xu WF; He XL; Dong YJ; Jiang NH; Su J; Lv GY; Chen SH
J Ethnopharmacol; 2024 Sep; 331():118274. PubMed ID: 38697410
[TBL] [Abstract][Full Text] [Related]
9. Modified Banxia Xiexin Decoction Ameliorates Polycystic Ovarian Syndrome With Insulin Resistance by Regulating Intestinal Microbiota.
Zhao H; Chen R; Zheng D; Xiong F; Jia F; Liu J; Zhang L; Zhang N; Zhu S; Liu Y; Zhao L; Liu X
Front Cell Infect Microbiol; 2022; 12():854796. PubMed ID: 35619648
[TBL] [Abstract][Full Text] [Related]
10. Addressing the role of 11β-hydroxysteroid dehydrogenase type 1 in the development of polycystic ovary syndrome and the putative therapeutic effects of its selective inhibition in a preclinical model.
Li X; Hu S; Zhu Q; Yao G; Yao J; Li J; Wang Y; Ding Y; Qi J; Xu R; Zhao H; Zhu Z; Du Y; Sun K; Sun Y
Metabolism; 2021 Jun; 119():154749. PubMed ID: 33722534
[TBL] [Abstract][Full Text] [Related]
11. Network pharmacology integrated with experimental validation reveals the regulatory mechanism of action of Hehuan Yin decoction in polycystic ovary syndrome with insulin resistance.
Wu YY; Li SY; Zhu HQ; Zhuang ZM; Shao M; Chen FL; Liu CS; Tang QF
J Ethnopharmacol; 2022 May; 289():115057. PubMed ID: 35121050
[TBL] [Abstract][Full Text] [Related]
12. Effects of total flavonoids from Eucommia ulmoides Oliv. leaves on polycystic ovary syndrome with insulin resistance model rats induced by letrozole combined with a high-fat diet.
Peng MF; Tian S; Song YG; Li CX; Miao MS; Ren Z; Li M
J Ethnopharmacol; 2021 Jun; 273():113947. PubMed ID: 33617969
[TBL] [Abstract][Full Text] [Related]
13. A Rat Model of Polycystic Ovary Syndrome with Insulin Resistance Induced by Letrozole Combined with High Fat Diet.
Wang MX; Yin Q; Xu X
Med Sci Monit; 2020 May; 26():e922136. PubMed ID: 32448863
[TBL] [Abstract][Full Text] [Related]
14. Randomized double-blind trial comparing low dose and conventional dose of a modified traditional herbal formula Guizhi Fuling Wan in women with symptomatic uterine fibroids.
Meng W; Lin WL; Yeung WF; Zhang Y; Ng EHY; Lee YPE; Zhang ZJ; Rong J; Lao L
J Ethnopharmacol; 2022 Jan; 283():114676. PubMed ID: 34562564
[TBL] [Abstract][Full Text] [Related]
15. [Effect of Qingre Yangyin Recipe on Endocrine and Metabolism of Polycystic Ovary Syndrome Patients].
Zhang T
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Oct; 35(10):1175-80. PubMed ID: 26677666
[TBL] [Abstract][Full Text] [Related]
16. Electroacupuncture ameliorates hepatic defects in a rat model of polycystic ovary syndrome induced by letrozole and a high-fat diet.
Huang S; Yu C; Hu M; Wen Q; Wen X; Li S; Li K; Ma H
Acupunct Med; 2024 Apr; 42(2):87-99. PubMed ID: 38044823
[TBL] [Abstract][Full Text] [Related]
17. Add-on effect of the Guizhi Fuling formula for management of reduced fertility potential in women with polycystic ovary syndrome: A systematic review and meta-analysis of randomized controlled trials.
Rong A; Ta N; E L; Meng W
Front Endocrinol (Lausanne); 2022; 13():995106. PubMed ID: 37143960
[TBL] [Abstract][Full Text] [Related]
18. Luteolin alleviates polycystic ovary syndrome in rats by resolving insulin resistance and oxidative stress.
Huang Y; Zhang X
Am J Physiol Endocrinol Metab; 2021 Jun; 320(6):E1085-E1092. PubMed ID: 33900851
[TBL] [Abstract][Full Text] [Related]
19. [Controlling effect of bushen huatan compound on the insulin signal conducting molecule inside ovaries in polycystic ovary syndrome model rats].
Liang C; Cong J; Chang H
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Dec; 31(12):1639-44. PubMed ID: 22384551
[TBL] [Abstract][Full Text] [Related]
20. Effects of Bu Shen Hua Zhuo formula on the LPS/TLR4 pathway and gut microbiota in rats with letrozole-induced polycystic ovary syndrome.
Wang Y; Xiao H; Liu Y; Tong Q; Yu Y; Qi B; Bu X; Pan T; Xing Y
Front Endocrinol (Lausanne); 2022; 13():891297. PubMed ID: 36017323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
